Not exact matches
Sydney - based Pacific Equity Partners and
global giant The Carlyle Group agreed to pay US - listed Valeant
Pharmaceuticals $ US930 million ($ 1.23 billion) for iNova on Thursday night, after winning a six - month auction for the
business.
From March 2014 to February 2015, Mr. Peery served as VP,
Global Business Services at Mylan N.V., a leading global pharmaceutical co
Global Business Services at Mylan N.V., a leading
global pharmaceutical co
global pharmaceutical company.
Sydney - based Pacific Equity Partners and
global giant The Carlyle Group agreed to pay US - listed Valeant
Pharmaceuticals $ US930 million ($ 1.23 billion) for iNova on Thursday night, after winning a six - month auction for the
business.
Meanwhile, a report from the McKinsey
Global Institute, a consulting firm, says that
businesses spanning virtually all sectors — from technology and social networking to
pharmaceuticals and health care — are using information gleaned from large data sets to help them operate more smoothly or to provide better products or services.
Unlike their
global counterparts, the Indian
pharmaceutical market — estimated at 400 billion Indian rupees (US $ 8 billion) in 2001 — is in a
business climate of token R&D investment.
Investing in the health - care sectorA dynamic sector: From biotech to
pharmaceuticals, the fund seeks out companies that profit from the
global demand for health care.A range of companies: The fund invests worldwide in
businesses at different stages of growth, from rapidly growing newer companies to established
global corporations.Actively managed: Unlike passively managed ETFs, Putnam
global sector funds combine rigorous fundamental research and disciplined quantitative analysis with macroeconomic views.
Notable mandates: The firm represented Mallinckrodt
Pharmaceuticals in connection with a
global corporate reorganization of its contrast media and delivery system
business and in connection with the US$ 270 - million sale of that
business to Paris - based Guerbet.
Pinsent Masons took the award for M&A Team of the Year (Medium - Sized Deal) in recognition of its work helping
pharmaceutical giant Teva acquire Allergan's
global generics
business.
Daniel has spent a number of years working in the city and time on secondment to a number of FTSE 100 clients including a
global bank, a
global telecommunications
business, a travel and leisure group and one of the world's leading
pharmaceutical companies.
Mr. Mirer serves as primary outside counsel concerning U.S. immigration matters for
global pharmaceutical and biotechnology companies and for United Technologies Corporation and all of its
business units operating in the United States.
Provided immigration training to human resources professionals, recruiters, executives and managers,
business owners, and in - house counsel for a variety of clients and
business organizations, including Fortune 100 and
Global 500 companies and one of the world's largest chemical and
pharmaceutical companies.
Galenica Group recently announced that it has entered into a definitive agreement to acquire the US company Relypsa, Inc., (NASDAQ: RLYP), further strengthening its
Business unit Vifor Pharma by gaining full
global rights to the potassium binder Veltassa ® (patiromer) for oral suspension and enhancing its growing position as a
global specialty
pharmaceutical company.
Eschbach joined
global pharmaceutical giant Novartis in 2001 as a legal counsel, subsequently assuming a number of different positions in the company, Eschbach moved up the ranks, assuming position as head legal, compliance and
business development in 2003 and five years later was bestowed the role of country legal head for Germany.
Prior to taking charge of BI's
global legal and compliance function, Dr Schwarz held a number of positions within BI, including senior counsel for licensing law and antitrust, head of corporate litigation and governmental investigations and head of corporate legal M&A and strategic transactions, in which role he oversaw the sale of BI's Roxane
business to Hikma
Pharmaceuticals in a $ 2.65 bn cash and stock deal.
Tags for this Online Resume: Medical, Marketing strategies, MBA, Budget management, problem solving and decision making skills,
global marketing startegies, distributor management,
business development,
pharmaceutical
Ronald D Collins, Sr P.O. Box 204 Santa Rosa, Ca 95402 (650) 518-4170 Goal: Seeking employment as a contract or telecommuting HR Professional Recruitment Consultant,
Business Development Executive, Director of Research &
Global Initiatives for Healthcare & Medicine, Biotechnology,
Pharmaceuticals, Information Technology, Banking & Finance Industries.
SUMMARY Commercial Operations Executive with 30 + years of consistent top performance in
pharmaceutical corporate headquarter and field sales positions, including
business practice compliance and quality,
global marketing support, sales and leadership training, and culture building while establishing revised visions.
Tags for this Online Resume: Compensation, Distribution, Messaging,
Business Plan, Financials, Forecast, Hematology, Mba, Oncology, marketing, sales, director, vice president, regional director, national director, launch, medical benefit, immunology, operations, strategy, leadership, execution, consistent, biotech,
pharmaceutical, Senior Director,
global, pricing, contracting
SUMMARY Over 14 years of engineering and
Global IT Program Management,
Business Management Professional with extensive experience in managing projects from concept to launch in various industries such as cellular telecommunication, retail,
pharmaceutical and distribution.